Specifically, butyric acid occupies lysine residues via butyrylation, thereby blocking lactylation of the GAPDH protein, which ultimately mitigates CAVD progression. This evidence concerns the gene GAPDH and congenital bilateral aplasia of vas deferens from CFTR mutation.